Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
10–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female
Aged 10 to less than (\<) 18 years at the time of signing informed consent
Diagnosed with type 2 diabetes mellitus greater than or equal to (\>=) 30 days prior to the day of screening
Glycated haemoglobin (HbA1c) less than or equal to (\<=) 10% (86 millimoles per mole \[mmol/mol\]) at screening
Treated with basal insulin, premix insulin or continuous subcutaneous insulin infusion (CSII) with or without bolus insulin or additional anti-diabetic drug(s).
Current daily basal insulin treatment \>= 0.2 (I) units per kilogram per day (U/kg/day) with stable doses \>=30 days prior to the day of screening
You may not be if
Known or suspected hypersensitivity to study interventions or related products
Female who is pregnant, breast-feeding or intends to become pregnant or is of childbearing potential and not using adequate contraceptive method
